David Sumerauer

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

Paul A. Northcott, Catherine Lee, Thomas Zichner et al. · Nature · 2014 · 662 citations · Full text

Oncogenic Agent, Genetics, Cancer Genetics +4

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

Pascal D. Johann, Serap Erkek, Marc Zapatka et al. · Cancer Cell · 2016 · 553 citations

Chromatin, Chromatin Remodeling, Medicine +10

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

Sebastian M. Waszak, Paul A. Northcott, Ivo Buchhalter et al. · The Lancet Oncology · 2018 · 383 citations · Full text

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

Ana Guerreiro Stücklin, Scott Ryall, Kohei Fukuoka et al. · Nature Communications · 2019 · 346 citations · Full text

Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas

Álvaro Lassaletta, Michal Zápotocký, Matthew Mistry et al. · Journal of Clinical Oncology · 2017 · 328 citations · Full text

Pediatric Brain Tumors, Tumor Innervation, Pathology +20